Pfizer Inc (NYSE:PFE) | Correction: Pfizer likely to report strong trial results, says BMO Capital

[theflyonthewall.com] – BMO Capital believes that the results of trials of Pfizer’s CAPITA and PALOMA-1 drugs are very likely to be positive. The firm recommends buying the stock ahead of clinical results of . . . → Read More: Pfizer Inc (NYSE:PFE) | Correction: Pfizer likely to report strong trial results, says BMO Capital Similar Articles: Medtronic Inc. (NYSE:MDT) | Medtronic hypertension device found ineffective in trial Company Update – AbbVie Inc. (NYSE:ABBV) – European drug trial secrecy case hit by delay More impetus for a summer stock market correction